More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$205223943
EPS
3.34
P/E ratio
22.7
Price to sales
6.57
Dividend yield
1.75%
Beta
0.382355
Previous close
$72.36
Today's open
$72.10
Day's range
$71.50 - $73.20
52 week range
$53.66 - $76.89
show more
CEO
Kevin L. Cornwell
Employees
152
Headquarters
Midvale, UT
Exchange
Nasdaq Global Select
Shares outstanding
2849541
Issue type
Common Stock
Healthcare
Medical Equipment & Supplies
Utah Medical Products: A $25 Million Buyback Isn't Enough
Utah Medical Products maintains a Hold rating due to ongoing revenue declines and concerns over capital allocation despite recent actions. UTMD's Q3 2026 saw a 12.1% revenue decline but a 5.9% net income increase, driven by lower litigation and amortization expenses. Management deployed cash via a $25M share repurchase at $75/share and acquired Orion Medical Supplies, aiming to offset core business weakness.
Seeking Alpha • Nov 13, 2026

Dividend Announcements: October 31-November 6, 2026 (Part 2 Of 2)
I monitor dividend increases and cuts across 1,200+ stocks, focusing on dividend growth streaks, safety, and valuation to identify high-conviction opportunities. In this second article in two parts, I highlight 17 Dividend Contenders and 2 special dividends this week. Snap-on (SNA) stands out with a 12.7% dividend hike, 17-year streak, 7.68 Quality Score, and top-tier dividend safety.
Seeking Alpha • Nov 9, 2026

UTMD's Q3 Earnings Rise Y/Y on Lower Costs, Orion Acquisition
Utah Medical's Q3 earnings per share rise 7% year over year despite a 12.1% revenue decline, aided by lower operating expenses. Management expects a smaller revenue decline for full-year 2026.
Zacks Investment Research • Oct 28, 2026

UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2026
SALT LAKE CITY, UT / ACCESS Newswire / October 22, 2026 / Utah Medical Products, Inc. (NASDAQ:UTMD) reports third quarter (3Q) and first nine months (9M) of calendar year 2026 financial results that include changes from the prior year's same period results. Currencies in this release are denoted as $ or USD = U.S. Dollars; AUD = Australia Dollars; £ or GBP = UK Pound Sterling; C$ or CAD = Canadian Dollars; and € or EUR = Euros.
Accesswire • Oct 22, 2026

UTMD Trades at a Premium to the Industry: How to Play the Stock?
Utah Medical's Orion acquisition, strong cash reserves, improving margins and product expansion efforts support growth prospects and continued shareholder returns.
Zacks Investment Research • Oct 8, 2026

Utah Medical Products, Inc. Extends Tender Offer
SALT LAKE CITY, UT / ACCESS Newswire / October 5, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) is offering to purchase up to 650,000 shares of its common stock at $75.00 per share. The Offer was initially scheduled to expire at 5:00 p.m.
Accesswire • Oct 5, 2026

Utah Medical Products, Inc. Clarifies Tender Offer Expiration Date
SALT LAKE CITY, UT / ACCESS Newswire / September 25, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) is offering to purchase up to 650,000 shares of its common stock at $75.00 per share. The conditions of the Offer are explained in detail in the SEC Form TO Offer to Purchase and Letter of Transmittal filed with the SEC at https://www.sec.gov/Archives/edgar/data/706698/000109690626001428/0001096906-26-001428-index.html The Offer is scheduled to expire at 5:00 p.m.
Accesswire • Sep 25, 2026

Utah Medical Products, Inc. Commences Tender Offer
SALT LAKE CITY, UT / ACCESS Newswire / September 24, 2026 / Utah Medical Products, Inc. (NASDAQ:UTMD) is offering to purchase up to 650,000 shares of its common stock at $75.00 per share. The $75.00 per share price represents a 17% premium over the average daily closing price of the stock during the last twelve months, and a 21% premium over the average daily closing price of the stock during the last twenty-four months.
Accesswire • Sep 24, 2026

UTMD Announces Self-Tender for 20% of Its Shares
SALT LAKE CITY, UT / ACCESS Newswire / September 15, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces today that it intends to repurchase at a price of $75.00 per share up to 650,000 of its shares, if tendered and not withdrawn by stockholders on or before October 7, representing approximately 20% of its currently outstanding shares. The offering price is 17% higher than the average daily closing price of UTMD shares trading in the open market during the last twelve months, and 21% higher than the average daily closing price of UTMD shares trading during the last two years.
Accesswire • Sep 15, 2026

Femcare Ltd Acquires Orion Medical Supplies Ltd in the UK
SALT LAKE CITY, UT / ACCESS Newswire / August 31, 2026 / Femcare Ltd. ("Femcare"), a wholly-owned subsidiary of Utah Medical Products, Inc. (Nasdaq:UTMD), announces that it has purchased the entire ordinary share capital of Orion Medical Supplies Ltd ("ORION") of the United Kingdom.
Accesswire • Aug 31, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Utah Medical Products Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.